Stability of an extemporaneously compounded minoxidil oral suspension

被引:6
作者
Song, Yunmei [1 ]
Chin, Zen Whey [1 ]
Ellis, David [2 ]
Lwin, Ei Mon Phyo [1 ]
Turner, Sean [2 ]
Williams, Desmond [1 ]
Garg, Sanjay [3 ]
机构
[1] Univ South Australia, Sch Pharm & Med Sci, Ctr Pharmaceut Innovat & Dev, Adelaide, SA, Australia
[2] Womens & Childrens Hosp, Dept Pharm, Adelaide, SA, Australia
[3] Univ South Australia, Sch Pharm & Med Sci, Adelaide, SA, Australia
关键词
chromatography; compounding; liquid; minoxidil; stability; storage; suspensions; HYPERTENSIVE CHILDREN; MEDICINES; THERAPY;
D O I
10.2146/ajhp160457
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Purpose. Results of a study to determine the stability of an extemporaneously compounded minoxidil oral suspension under various temperature and stress conditions are reported. Methods. Commercially available minoxidil tablets (10 mg) were crushed to a fine powder, and predetermined amounts of 2 suspending vehicles were added to produce a 1-mg/mL suspension, which was stored in glass bottles at room temperature (25 +/- 2 degrees C) or in a refrigerator (4 +/- 2 degrees C). To simulate daily patient use, 5 days weekly 1 bottle of the suspension was removed from refrigerated storage and shaken and 0.5 mL of the contents discarded. At each specified time point, samples were analyzed in duplicate (n = 6 for each test condition) using a validated high-performance liquid chromatography method. Samples were visually observed and their pH measured at each time point. Microbiological studies were performed on day 0 and at week 24. Results. The mean percentage of initial minoxidil concentration remaining in all refrigerated samples exceeded 90% throughout the 24-week study, with no change in appearance, pH, microbial activity, odor, or redispersibility. During storage at room temperature, the suspension exhibited a color change at week 4, with slight sedimentation after 6 weeks, although minoxidil recovery exceeded 90% for 10 weeks. Conclusion. An extemporaneously compounded minoxidil oral suspension was stable for 24 weeks when stored in a refrigerator. This suspension can be used for up to 3 weeks when stored at room temperature.
引用
收藏
页码:309 / 315
页数:7
相关论文
共 50 条
[31]   Stability of terbinafine hydrochloride in an extemporaneously prepared oral suspension at 25 and 4 °C [J].
Abdel-Rahman, SM ;
Nahata, MC .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1999, 56 (03) :243-245
[32]   Stability of acetylcysteine in an extemporaneously compounded ophthalmic solution [J].
Anaizi, NH ;
Swenson, CF ;
Dentinger, PJ .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1997, 54 (05) :549-553
[33]   Stability of vancomycin in an extemporaneously compounded ophthalmic solution [J].
Fuhrman, LC ;
Stroman, RT .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1998, 55 (13) :1386-1388
[34]   Stability of bethanechol chloride, pyrazinamide, quinidine sulfate, rifampin, and tetracycline hydrochloride in extemporaneously compounded oral liquids [J].
Allen, LV ;
Erickson, MA .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1998, 55 (17) :1804-1809
[35]   Stability of labetalol hydrochloride, metoprolol tartrate, verapamil hydrochloride, and spironolactone with hydrochlorothiazide in extemporaneously compounded oral liquids [J].
Allen, LV ;
Erickson, MA .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1996, 53 (19) :2304-2309
[36]   Stability of ketoconazole, metolazone, metronidazole, procainamide hydrochloride, and spironolactone in extemporaneously compounded oral liquids [J].
Allen, LV ;
Erickson, MA .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1996, 53 (17) :2073-2078
[37]   Stability of baclofen, captopril, diltiazem hydrochloride, dipyridamole, and flecainide acetate in extemporaneously compounded oral liquids [J].
Allen, LV ;
Erickson, MA .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1996, 53 (18) :2179-2184
[38]   Stability of extemporaneously prepared rosuvastatin oral suspension [J].
Zaid, Abdel Naser ;
Shtayah, Rania ;
Qadumi, Ayman ;
Ghanem, Mashour ;
Qedan, Rawan ;
Daibes, Marah ;
Abu Awwad, Somud ;
Jaradat, Nidal ;
Kittana, Naim .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2017, 74 (19) :1579-1583
[39]   STABILITY OF FAMOTIDINE IN AN EXTEMPORANEOUSLY PREPARED ORAL LIQUID [J].
QUERCIA, RA ;
JAY, GT ;
FAN, CD ;
CHOW, MSS .
AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1993, 50 (04) :691-693
[40]   Stability of norfloxacin in an extemporaneously prepared oral liquid [J].
Johnson, CE ;
Price, J ;
Hession, JM .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2001, 58 (07) :577-579